Radiation Sickness Latest Advances

Pharmacokinetic Characterization of the Gastrointestinal Acute Radiation Syndrome Mitigator YK-4-250 in Male and Female Mice Under Non-Irradiated and Partial Body Irradiation Conditions.

Journal: Research square

Published: July 17, 2026

Immunometabolic mechanisms of ionizing radiation in a mouse model of gastrointestinal acute radiation syndrome.

Journal: International journal of radiation biology

Published: June 23, 2026

Parameterization of Hematopoietic Acute Radiation Syndrome Mortality Based on Models of Neutrophil Kinetics.

Journal: Journal of radiological protection : official journal of the Society for Radiological Protection

Published: June 23, 2026

Ghrelin Induces Clu+ Revival Stem Cells and Regenerates Lgr5+ Stem Cells via the Vagus Nerve to Mitigate Gastrointestinal Acute Radiation Syndrome.

Journal: International journal of molecular sciences

Published: May 26, 2026

Pharmacokinetics, pharmacodynamics, and radiomitigative efficacy of IEPA in a non-human primate model of acute radiation syndrome.

Journal: International journal of radiation biology

Published: May 26, 2026

Multiphasic blood transcriptomic signatures of radioprotection by BIO 300, a synthetic genistein nanosuspension, in a nonhuman primate model of acute radiation syndrome.

Journal: Journal of translational medicine

Published: April 28, 2026

Delayed Radiation Injuries (Soft Tissue and Bony Necrosis) and Potential for Future Research.

Journal: Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc

Published: April 14, 2026

YK-4-250 mitigates gastrointestinal radiation syndrome and promotes overall survival following partial body radiation injury.

Journal: Scientific reports

Published: March 31, 2026

Intelligent model for stratification of acute radiation syndrome severity in humans.

Journal: International journal of radiation biology

Published: March 05, 2026

Cytokine use in the Hematopoietic Subsyndrome of Acute Radiation Syndrome (H-ARS): Implications for the role of cytokines in a mass casualty radiologic/nuclear (R/N) emergency.

Journal: Journal of radiological protection : official journal of the Society for Radiological Protection

Published: February 12, 2026

Bone Marrow Colony Stimulating Factors (CSF) and Stem Cell Therapy as Medical Countermeasures (MCM) for Treatment of Hematopoietic-Acute Radiation Syndrome: A Systematic Review.

Journal: Disaster medicine and public health preparedness

Published: February 09, 2026

A Defined Patho-Mechanism for Acute Radiation Syndrome Death and a Three-Drug Regimen to Prevent It.

Journal: International journal of molecular sciences

Published: February 07, 2026

Radiation Sickness Latest Advances

Find the Latest Research About Radiation Sickness

Pharmacokinetic Characterization of the Gastrointestinal Acute Radiation Syndrome Mitigator YK-4-250 in Male and Female Mice Under Non-Irradiated and Partial Body Irradiation Conditions.

Pharmacokinetic Characterization of the Gastrointestinal Acute Radiation Syndrome Mitigator YK-4-250 in Male and Female Mice Under Non-Irradiated and Partial Body Irradiation Conditions.

Immunometabolic mechanisms of ionizing radiation in a mouse model of gastrointestinal acute radiation syndrome.

Immunometabolic mechanisms of ionizing radiation in a mouse model of gastrointestinal acute radiation syndrome.

Parameterization of Hematopoietic Acute Radiation Syndrome Mortality Based on Models of Neutrophil Kinetics.

Parameterization of Hematopoietic Acute Radiation Syndrome Mortality Based on Models of Neutrophil Kinetics.

Ghrelin Induces Clu+ Revival Stem Cells and Regenerates Lgr5+ Stem Cells via the Vagus Nerve to Mitigate Gastrointestinal Acute Radiation Syndrome.

Ghrelin Induces Clu+ Revival Stem Cells and Regenerates Lgr5+ Stem Cells via the Vagus Nerve to Mitigate Gastrointestinal Acute Radiation Syndrome.

Pharmacokinetics, pharmacodynamics, and radiomitigative efficacy of IEPA in a non-human primate model of acute radiation syndrome.

Pharmacokinetics, pharmacodynamics, and radiomitigative efficacy of IEPA in a non-human primate model of acute radiation syndrome.

Multiphasic blood transcriptomic signatures of radioprotection by BIO 300, a synthetic genistein nanosuspension, in a nonhuman primate model of acute radiation syndrome.

Multiphasic blood transcriptomic signatures of radioprotection by BIO 300, a synthetic genistein nanosuspension, in a nonhuman primate model of acute radiation syndrome.

Delayed Radiation Injuries (Soft Tissue and Bony Necrosis) and Potential for Future Research.

Delayed Radiation Injuries (Soft Tissue and Bony Necrosis) and Potential for Future Research.

YK-4-250 mitigates gastrointestinal radiation syndrome and promotes overall survival following partial body radiation injury.

YK-4-250 mitigates gastrointestinal radiation syndrome and promotes overall survival following partial body radiation injury.

Intelligent model for stratification of acute radiation syndrome severity in humans.

Intelligent model for stratification of acute radiation syndrome severity in humans.

Cytokine use in the Hematopoietic Subsyndrome of Acute Radiation Syndrome (H-ARS): Implications for the role of cytokines in a mass casualty radiologic/nuclear (R/N) emergency.

Cytokine use in the Hematopoietic Subsyndrome of Acute Radiation Syndrome (H-ARS): Implications for the role of cytokines in a mass casualty radiologic/nuclear (R/N) emergency.

Bone Marrow Colony Stimulating Factors (CSF) and Stem Cell Therapy as Medical Countermeasures (MCM) for Treatment of Hematopoietic-Acute Radiation Syndrome: A Systematic Review.

Bone Marrow Colony Stimulating Factors (CSF) and Stem Cell Therapy as Medical Countermeasures (MCM) for Treatment of Hematopoietic-Acute Radiation Syndrome: A Systematic Review.

A Defined Patho-Mechanism for Acute Radiation Syndrome Death and a Three-Drug Regimen to Prevent It.

A Defined Patho-Mechanism for Acute Radiation Syndrome Death and a Three-Drug Regimen to Prevent It.